RPG Life Sciences consolidated net profit declines 74.52% in the March 2026 quarter

Sales rise 23.62% to Rs 176.89 crore

Net profit of RPG Life Sciences declined 74.52% to Rs 29.90 crore in the quarter ended March 2026 as against Rs 117.35 crore during the previous quarter ended March 2025. Sales rose 23.62% to Rs 176.89 crore in the quarter ended March 2026 as against Rs 143.09 crore during the previous quarter ended March 2025.

For the full year,net profit declined 37.15% to Rs 115.17 crore in the year ended March 2026 as against Rs 183.24 crore during the previous year ended March 2025. Sales rose 8.28% to Rs 707.52 crore in the year ended March 2026 as against Rs 653.43 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	176.89	143.09	24	707.52	653.43	8
OPM %	18.56	17.81	-	20.79	24.43	-
PBDT	44.84	30.37	48	171.78	171.71	0
PBT	39.10	25.00	56	150.30	150.28	0
NP	29.90	117.35	-75	115.17	183.24	-37

Powered by Capital Market - Live News